BioCentury
ARTICLE | Company News

Genzyme sales and marketing update

July 27, 2009 7:00 AM UTC

Genzyme launched Renvela sevelamer carbonate in Europe to control serum phosphorus in patients with chronic kidney disease (CKD), including those not on dialysis. The European approval includes both ...